Anevski Peter reported option exercise involving 185,134 derivative units of Progyny, Inc. at $0.00 for $0 on Nov 10, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
CHIEF EXECUTIVE OFFICER
CHIEF EXECUTIVE OFFICER
Filed Nov 12, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
185,134Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
157,369Direct
Trade date
Nov 10, 2026Option exercise
Filed
Nov 12, 2026, 5:31 PM ET2-day reporting delay
Accession
0001551306-26-000181Code M · Transaction 399534
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 10, 2026Sell120,213$35.61−$4,280,400.25Trade 399530
Nov 10, 2026Sell64,921$36.29−$2,355,664.98Trade 399531
Nov 10, 2026Sell33,437$35.61−$1,190,581.23Trade 399532
Nov 10, 2026Sell18,059$36.29−$655,272.62Trade 399533
Nov 10, 2026Option exercise185,134$0.91$168,471.94Trade 399529
6 transaction rows in this filing. Joint filers share the same rows.

PGNY price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PGNY · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −24%1w ago −21%1d ago −1.7%
Returns since7d30d90d180d1y

Footnotes in full

F1: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 2, 2026. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote F4: These options are fully vested and exercisable.